Brief: Mainz Biomed Initiates Feasibility Study Of Biomarker Panel In Pancreatic Cancer Project
10/06/2025 15:22
June 10 (Reuters) - Mainz Biomed NV 4TO.F: MAINZ BIOMED INITIATES FEASIBILITY STUDY OF BIOMARKER PANEL IN PANCREATIC CANCER PROJECT Source text: ID:nGNX1pfTGH Further company coverage: 4TO.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quantum Cyber NV
See all newsBrief: Quantum Cyber To Proceed With Pending Litigation Against Adam Gefvert
Brief: Quantum Cyber NV Files Lawsuit Against White Diamond Research, Adam Gefvert And Stocktwits, Inc. In New York Supreme Court
Quantum Cyber jumps on SpaceX stake purchase plan
Brief: Quantum Cyber Signs Loi To Acquire An Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility To Support Mass-Scale Autonomous Drone Production
Brief: Quantum Cyber NV - To Terminate ATM Sales Agreement With Maxim Effective June 7, 2026 - SEC Filing